Patient Information Leaflet
Fycompa 2mg, 4mg, 6mg, 8mg, 10mg and 12mg Film-Coated Tablets
perampanel
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1.What is Fycompa and what it is used for
2.What you need to know before you start taking Fycompa
3.How to take Fycompa
4.Side effects
5. Storage of Fycompa
6.Contents of the pack and additional information
Fycompa contains a medicine called perampanel. It belongs to a group of medicines called antiepileptics. These medicines are used to treat epilepsy, when a person has repeated seizure attacks (convulsive crises). Your doctor has prescribed it for you to reduce the number of seizure attacks you have.
Fycompa is used in combination with other antiepileptics to treat specific forms of epilepsy in people:
in adults, adolescents (12 years of age and older) and children (4 to 11 years of age)
in adults, adolescents (12 years of age and older) and children (7 to 11 years of age)
DO NOT TAKE Fycompa:
-if you have ever had a severe skin rash or skin peeling, blisters, and/or mouth sores after taking perampanel.
-if you are allergic to perampanel or any of the other ingredients in this medication (listed in section 6).
Warnings and Precautions
Consult your doctor or pharmacist before starting Fycompa if you have liver problems or moderate to severe kidney problems.
You should not take Fycompa if you have severe liver problems or moderate to severe kidney problems.
Before starting this medication, you must inform your doctor if you have a history of alcoholism or drug dependence.
There have been reports of increased liver enzymes in some patients taking Fycompa with other antiepileptic medications.
-Fycompa may make you feel dizzy or drowsy, especially at the beginning of treatment.
-Fycompa may make you more prone to falls, especially if you are an older person; this could be due to your condition.
-Fycompa may make you become aggressive, furious, or violent. It may also cause unusual or extreme changes in your behavior or mood, abnormal thoughts, or loss of contact with reality.
If you, a family member, or a friend notice any of these reactions, consult your doctor or pharmacist.
A reduced number of people taking antiepileptic medications have had thoughts of self-harm or suicide. If, at any time, you have these thoughts, consult your doctor immediately.
There have been reports of severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), and Stevens-Johnson syndrome (SSJ), associated with perampanel treatment.
If you experience any of the above problems after taking Fycompa (or are unsure), consult your doctor or pharmacist.
Children
Fycompa is not recommended for children under 4 years old. The safety and efficacy in children under 4 years old for partial seizures, and under 7 years old for generalized seizures, have not been established.
Other Medications and Fycompa
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes over-the-counter medications and herbal medications. Taking Fycompa with some other medications may cause adverse effects or affect how they work. Do not start or stop taking other medications without consulting your doctor or pharmacist.
-Other antiepileptic medications, such as carbamazepine, oxcarbazepine, and phenytoin, used to treat seizures, may affect Fycompa. Inform your doctor if you are taking or have taken these medications recently, as your dose may need to be adjusted.
-Felbamate (a medication used to treat epilepsy) may also affect Fycompa. Inform your doctor if you are taking or have taken this medication recently, as your dose may need to be adjusted.
-Other medications, such as rifampicin (a medication used to treat bacterial infections), St. John's Wort (a medication used to treat mild anxiety), and ketoconazole (a medication used to treat fungal infections), may affect Fycompa. Inform your doctor if you are taking or have taken these medications recently, as your dose may need to be adjusted.
-Birth control medications (including oral contraceptives, implants, injections, and patches).
Inform your doctor if you are taking birth control medications. Fycompa may make certain birth control medications, such as levonorgestrel, less effective. You should use other safe and effective birth control methods (such as condoms or an intrauterine device) while taking Fycompa. You should continue to do so for a month after stopping treatment. Consult your doctor about which birth control method is suitable for you.
Fycompa and Alcohol
Discuss with your doctor before taking alcohol. Be careful with alcohol consumption and epilepsy medications, including Fycompa.
-Drinking alcohol while taking Fycompa may reduce your alertness and affect your ability to drive or use tools and machines.
-Drinking alcohol while taking Fycompa may also worsen any feelings of anger, confusion, or sadness.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication. Do not stop treatment without consulting your doctor first.
-Fycompa is not recommended during pregnancy.
-You should use a reliable birth control method to prevent pregnancy while receiving Fycompa treatment. You should continue to do so for a month after stopping treatment. Inform your doctor if you are taking birth control medications. Fycompa may make certain birth control medications, such as levonorgestrel, less effective. You should use other safe and effective birth control methods (such as condoms or an intrauterine device) while taking Fycompa. You should also do so for a month after stopping treatment. Consult your doctor about which birth control method is suitable for you.
The safety of Fycompa components in breast milk is unknown.
Your doctor will weigh the benefits of Fycompa treatment for the mother against the risks for the baby while breastfeeding.
Driving and Using Machines
Do not drive or use machines until you know how Fycompa affects you.
You should discuss with your doctor about the effect of epilepsy on driving and using machines.
-Fycompa may make you feel dizzy or drowsy, especially at the beginning of treatment. If this happens, do not drive or use tools or machines.
-Drinking alcohol while taking Fycompa may worsen these effects.
Fycompa Contains Lactose
Fycompa contains lactose (a type of sugar). If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
How much to take
Adults and adolescents (12 years of age and older) in the treatment of partial seizures and generalized seizures
The recommended initial dose is 2 mg (4 ml) once a day before bedtime.
-Your doctor may increase this dose in increments of 2 mg (4 ml) up to a maintenance dose between 4 mg (8 ml) and 12 mg (24 ml), depending on your response.
-If you have mild or moderate liver problems, your dose should not exceed 8 mg per day and dose increases should be made with an interval of at least 2 weeks.
-Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.
In the following table, the recommended doses for the treatment of partial seizures in children aged 4 to 11 years and generalized seizures in children aged 7 to 11 years are shown. For more information, see below the table.
Children who weigh: | ||
More than 30 kg | 20 kg to no more than 30 kg | Less than 20 kg |
Recommended initial dose | 2 mg/day (4 ml/day) | 1 mg/day (2 ml/day) |
Recommended maintenance dose | 4-8 mg/day (8-16 ml/day) | 2-4 mg/day (4-8 ml/day) |
Maximum recommended dose | 12 mg/day (24 ml/day) | 6 mg/day (12 ml/day) |
Children (4 to 11 years of age) who weigh 30 kg or more in the treatment of partial seizures:
The recommended initial dose is 2 mg (4 ml) once a day before bedtime.
Children (4 to 11 years of age) who weigh 20 kg to less than 30 kg in the treatment of partial seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Children (4 to 11 years of age) who weigh less than 20 kg in the treatment of partial seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Children (7 to 11 years of age) who weigh 30 kg or more in the treatment of generalized seizures:
The recommended initial dose is 2 mg (4 ml) once a day before bedtime.
Children (7 to 11 years of age) who weigh 20 kg to less than 30 kg in the treatment of generalized seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
Children (7 to 11 years of age) who weigh less than 20 kg in the treatment of generalized seizures:
The recommended initial dose is 1 mg (2 ml) once a day before bedtime.
How to take
Fycompa is administered orally. Fycompa can be taken with or without food and should be taken in the same way every time. For example, if you decide to take Fycompa with food, take it with food every time.
Use the oral syringe and adapter provided for administration.
Below are the instructions for use of the oral syringe and adapter:
1.Shake well before use.
2.Press and (1) turn the cap (2) to open the bottle.
3.Insert the adapter into the neck of the bottle until it is securely closed.
4.Insert the plunger of the syringe completely.
5.Insert the syringe into the opening of the adapter as far as possible.
6.Place the bottle upside down and extract the prescribed amount of Fycompa.
7.Place the bottle right side up and remove the syringe.
8.Leave the adapter in place and replace the cap on the bottle.
9.After administering the dose, separate the body and plunger and submerge them completely in warm soapy water.
10.Submerge the body and plunger in water to remove detergent residue, shake off excess water, and let air dry. Do not manually dry the dispensers.
11.Do not clean or reuse the syringe after 40 uses or if the syringe marks are erased when washing.
.
If you take more Fycompa than you should
If you have taken more Fycompa than you should, consult your doctor immediately. You may experience drowsiness, agitation, aggressive behavior, and decreased level of consciousness.
If you forget to take Fycompa
-If you forget to take Fycompa, wait until it is time to take the next dose and continue as usual.
-Do not take a double dose to make up for the missed doses.
-If you have missed less than 7 days of Fycompa treatment, continue taking the daily dose as originally indicated by your doctor.
-If you have missed more than 7 days of Fycompa treatment, consult your doctor immediately.
If you interrupt Fycompa treatment
Take Fycompa for the recommended time by your doctor. Do not interrupt treatment unless your doctor advises you to. Your doctor may gradually reduce your dose to prevent seizures from returning or worsening.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
A reduced number of people taking antiepileptic medications have had thoughts of self-harm or suicide. If, at any time, you have these thoughts, consult your doctor immediately.
Very common(may affect more than 1in 10users):
-dizziness
-drowsiness (drowsiness or somnolence)
Common(may affect up to 1in 10users):
-increased or decreased appetite, weight gain
-feeling of aggression, anger, irritability, anxiety, or confusion
-difficulty walking or other balance problems (ataxia, gait disorder, balance disorder)
-slow speech (dysarthria)
-blurred vision or double vision (diplopia)
-feeling that everything is spinning (vertigo)
-nausea (gag reflex)
-back pain
-feeling extremely tired (fatigue)
-falls
Rare(may affect up to 1in 100users):
-thoughts of self-harm or suicide, attempt to end life (suicide attempt)
-hallucinations (seeing, hearing, or feeling things that do not exist)
-abnormal thoughts or loss of contact with reality (psychotic disorder)
Unknown frequency(the frequency of this side effect cannot be estimated from available data):
Stop using perampanel if any of these symptoms appear and consult your doctor or seek immediate medical attention. See also section2.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSistema Español de Farmacovigilancia de medicamentos de Uso Humanowww.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label of the bottle and on the box. The expiration date is the last day of the month indicated.
No special storage conditions are required.
If more than 90days have passed since the first opening, do not use the remaining suspension in the bottle.
Medications should not be thrown away through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.
Composition of Fycompa
The active ingredient is perampanel. Each milliliter contains 0.5 mg of perampanel.
The other components are sorbitol (E420) liquid (crystallizing), microcrystalline cellulose (E460), sodium carboxymethylcellulose (E466), poloxamer 188, simethicone emulsion at 30% (contains purified water, silicone oil, polysorbate 65, methylcellulose, silica gel, stearyl macrogol, citric acid anhydrous (E330), sodium benzoate (E211), and sulfuric acid), citric acid anhydrous (E330), sodium benzoate (E211), and purified water.
Appearance of the product and contents of the package
Fycompa 0.5 mg/ml oral suspension is a white to off-white suspension. It is presented in a 340 ml bottle with 2 oral syringes graduated for use and a pressure bottle adapter (PIBA).
Marketing Authorization Holder
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
e-mail: [email protected]
Responsible for manufacturing
Eisai GmbH
Edmund-Rumpler-Straße 3
60549 Frankfurt am Main
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Eisai SA/NV Tel: +32 (0)800 158 58 | Lithuania Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) |
... Eisai GmbH Tel: + 49 (0) 69 66 58 50 (... | Luxembourg/Luxemburg Eisai SA/NV Tel: +32 (0)800 158 58 (Belgium/Belgien) |
Czech Republic Eisai GesmbH organizational unit Tel: + 420 242 485 839 | Hungary Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) |
Denmark Eisai AB Tel: + 46 (0) 8 501 01 600 (Sweden) | Malta Cherubino LTD Tel: +356 21343270 |
Germany Eisai GmbH Tel: + 49 (0) 69 66 58 50 | Netherlands Eisai B.V. Tel: + 31 (0) 900 575 3340 |
Estonia Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) | Norway Eisai AB Tel: + 46 (0) 8 501 01 600 (Sweden) |
Greece Arriani Pharmaceutical S.A. Tel: + 30 210 668 3000 | Austria Eisai GesmbH Tel: + 43 (0) 1 535 1980-0 |
Spain Eisai Farmacéutica, S.A. Tel: + (34) 91 455 94 55 | Poland Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) |
France Eisai SAS Tel: + (33) 1 47 67 00 05 | Portugal Eisai Farmacêtica, Unipessoal Lda Tel: + 351 214 875 540 |
Croatia Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) | Romania Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) |
Ireland Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) | Slovakia Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Slovakia) |
Iceland Eisai AB Tel: + 46 (0)8 501 01 600 (Sweden) | Slovenia Eisai GesmbH organizational unit Tel: + 420 242 485 839 (Czech Republic) |
Italy Eisai S.r.l. Tel: + 39 02 5181401 | Finland Eisai AB Tel: + 46 (0) 8 501 01 600 (Sweden) |
Cyprus Arriani Pharmaceuticals S.A. Tel: + 30 210 668 3000 (Greece) | Sweden Eisai AB Tel: + 46 (0) 8 501 01 600 |
Lithuania Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) | United Kingdom (Northern Ireland) Eisai GmbH Tel: + 49 (0) 69 66 58 50 (Germany) |
Last review date of this leaflet:
The detailed information about this medication is available on the European Medicines Agency website: http://www.ema.europa.eu/.
The average price of Fycompa 0,5 mg/ml suspension oral in July, 2025 is around 96.97 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.